Miglustat Treatment Reverses Altered Secondary Lipids and Inflammatory Markers in Lysosomal Sialidase Neu1 Deficient Fibroblasts
| dc.contributor.author | Ada, E. | |
| dc.contributor.author | Demir, S. Akyildiz | |
| dc.contributor.author | Seyrantepe, V. | |
| dc.date.accessioned | 2025-10-25T17:45:01Z | |
| dc.date.available | 2025-10-25T17:45:01Z | |
| dc.date.issued | 2025 | |
| dc.identifier.issn | 2211-5463 | |
| dc.identifier.uri | https://hdl.handle.net/11147/18594 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley | en_US |
| dc.relation.ispartof | FEBS Open Bio | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Miglustat Treatment Reverses Altered Secondary Lipids and Inflammatory Markers in Lysosomal Sialidase Neu1 Deficient Fibroblasts | |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.author.wosid | Demir, Seçil/Hge-7242-2022 | |
| gdc.coar.type | text::conference output | |
| gdc.description.department | İzmir Institute of Technology | en_US |
| gdc.description.departmenttemp | Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkiye | en_US |
| gdc.description.endpage | 376 | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.startpage | 376 | en_US |
| gdc.description.volume | 15 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded | |
| gdc.description.wosquality | Q3 | |
| gdc.identifier.wos | WOS:001552034504051 | |
| gdc.index.type | WoS | |
| gdc.wos.citedcount | 0 | |
| relation.isAuthorOfPublication.latestForDiscovery | cc5dbf8a-47c5-463f-8e8c-888beaf37b02 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4003-8abe-a4dfe192da5e |